Open AccessAcquired Hemophilia A Secondary to an Immune Checkpoint Inhibitor: A Case Report
Author(s) -
James Fletcher,
R. Byron Bird,
Andrew JW. McLean,
Kenneth J. O’Byrne,
Wen Xu
Publication year - 2022
Publication title -
jto clinical and research reports
Language(s) - English
Resource type - Journals
ISSN - 2666-3643
DOI - 10.1016/j.jtocrr.2022.100409
Subject(s) - medicine , atezolizumab , prednisolone , rituximab , adverse effect , asymptomatic , recombinant factor viia , methylprednisolone , surgery , immunology , gastroenterology , immunotherapy , antibody , cancer , pembrolizumab